Baxter International Inc. $BAX Shares Sold by South Dakota Investment Council

South Dakota Investment Council decreased its stake in shares of Baxter International Inc. (NYSE:BAX – Free Report) by 48.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 189,329 shares of the medical instruments supplier’s stock after selling 177,415 shares during the quarter. South Dakota Investment Council’s holdings in Baxter International were worth $4,544,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in shares of Baxter International in the second quarter worth $1,744,874,000. Pzena Investment Management LLC bought a new position in shares of Baxter International during the second quarter valued at $1,392,098,000. Equity Investment Corp bought a new position in shares of Baxter International during the second quarter valued at $146,815,000. Bank of America Corp DE bought a new position in shares of Baxter International during the second quarter valued at $132,993,000. Finally, Aberdeen Group plc raised its position in shares of Baxter International by 16,776.9% in the 3rd quarter. Aberdeen Group plc now owns 3,743,975 shares of the medical instruments supplier’s stock worth $89,855,000 after purchasing an additional 3,721,791 shares during the last quarter. Hedge funds and other institutional investors own 90.19% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on BAX shares. Weiss Ratings upgraded shares of Baxter International from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, October 30th. JPMorgan Chase & Co. cut their price objective on shares of Baxter International from $26.00 to $25.00 and set a “neutral” rating on the stock in a research report on Friday, October 30th. UBS Group raised their price objective on shares of Baxter International from $19.00 to $25.00 and gave the company a “hold” rating in a research note on Tuesday, July 28th. Zacks Research raised shares of Baxter International from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 11th. Finally, Wall Street Zen raised shares of Baxter International from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. One research analyst has rated the stock with a Buy rating, ten have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Reduce” and a consensus price target of $23.27.

Get Our Latest Stock Analysis on BAX

Baxter International Stock Up 1.5%

BAX opened at $26.16 on Thursday. The stock has a market capitalization of $13.53 billion, a price-to-earnings ratio of -18.55, a PEG ratio of 3.79 and a beta of 0.68. The firm has a 50 day moving average price of $24.58 and a 200-day moving average price of $21.76. Baxter International Inc. has a twelve month low of $15.73 and a twelve month high of $30.00. The company has a quick ratio of 1.19, a current ratio of 1.79 and a debt-to-equity ratio of 1.20.

Baxter International (NYSE:BAX – Get Free Report) last issued its earnings results on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.06. Baxter International had a negative net margin of 6.23% and a positive return on equity of 16.23%. The company had revenue of $2.98 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter last year, the company posted $0.69 earnings per share. The firm’s quarterly revenue was up 5.0% on a year-over-year basis. Equities research analysts forecast that Baxter International Inc. will post 2.10 earnings per share for the current year.

Baxter International Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Friday, November 27th will be issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, November 27th. Baxter International’s dividend payout ratio is presently -2.84%.

About Baxter International

(Free Report)

Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.

Featured Articles

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX – Free Report).

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.